The Pro-inflammatory cytokine, Interleukin 17A (IL-17A) plays a vital role in the pathogenesis of inflammatory-induced acute lung injury (ALI). But, the mechanisms of this pro-inflammatory cytokine in response to activation after replication stress are not yet known. Control on DNA replication (DR) is vital for maintaining genome stability. Minichromosome maintenance (MCM) proteins play essential roles in various cancers, but their involvement during ALI is not yet been discussed. The present study was carried out to assess the participation of IL-17A during replication stress and to evaluate the contribution of curcumin on this. Mass spectrometry-based proteomic approach has been used on mice lung tissues treated with IL-17A, as a prime mediator to cause injury and curcumin a natural polyphenol as an intervention. Several trends were identified from the proteomic subset which revealed that IL-17A induces expressions of proteins like MCM2, MCM3, and MCM6 along with other proteins involved in DR. Interestingly, curcumin was found in suppressing the expression levels of these proteins. This was also confirmed via validating LC-MS/MS data using appropriate molecular techniques. Pathway and gene ontology analysis were performed with DAVID GO databases. Apart from this, the present study also reports the unique contribution of curcumin in suppressing the mRNA levels of other MCMs like MCM4, MCM5, and MCM7 as well as of ORC1 and ORC2. Hence, the present study revolves around linking the replication stress by pro-inflammatory effects, highlighting the implications for ALI and therapies. This study, therefore, enhances our capacity to therapeutically target DR-specific proteins.
Post-translational modifications (PTMs) play central roles in regulating protein function, localization, stability, and signaling networks. Comprehensive characterization of multiple PTMs, however, remains technically challenging due to limited sample availability, enrichment, incompatibilities, and analytical complexity. Here, we present an integrated serial enrichment workflow that enables quantitative profiling of multiple PTMs from a single biological sample. Using a streamlined strategy that combines StageTip-based fractionation with sequential immunoaffinity and metal oxide affinity enrichment, we achieved robust identification and quantification of lysine acetylation, lysine succinylation, phosphotyrosine, and global phosphorylation within the same sample. Application of this workflow resulted in deep proteome coverage alongside high-confidence PTM site identification with minimal sample loss and high reproducibility. Importantly, serial enrichment preserved PTM specificity and enabled comparative quantitative analysis across modification types. This approach provides a practical and scalable solution for integrated multi-PTM analysis, facilitating comprehensive interrogation of proteome regulation under limited sample conditions and offering broad applicability to systems biology, disease profiling, and translational proteomics studies.
Phosphorylation driven dysregulation of intracellular signaling networks is a central feature of cancer initiation, progression, and therapeutic resistance. Although Annona muricata leaf extracts have demonstrated anticancer activity across multiple experimental models, the underlying molecular mechanisms particularly at the level of phosphorylation dependent signaling remain poorly understood. In this study, we employed a tandem mass tag TMT-based quantitative phosphoproteomic approach to systematically characterize signaling alterations induced by methanolic Annona muricata leaf extract (AME) in oral squamous cell carcinoma (OSCC) CAL-27 cells. Functional assays revealed that AME significantly inhibited cell proliferation, migration, and clonogenic survival. Global phosphoproteomic profiling identified 6,362 phosphopeptides corresponding to 1,964 unique phosphorylation sites across nearly 7,000 phosphoproteins. AME treatment induced widespread, time-dependent hypophosphorylation, indicating a coordinated suppression of oncogenic signaling networks. Pathway and network analyses revealed marked inhibition of signaling pathways associated with key oncogenic kinases, including cyclin-dependent kinases (CDKs), mitogen-activated protein kinases (MAPKs), and signaling modules linked to EGFR and mTOR pathways. Kinase-substrate enrichment and kinome mapping further demonstrated reduced inferred activity of CDK and MAPK driven signaling, accompanied by suppression of cell cycle progression, mitosis, and checkpoint regulation. Collectively, these findings demonstrate that AME induces systems-level remodeling of phosphorylation dependent signaling networks, enforcing a growth-restrictive cellular state in OSCC cells. This study highlights quantitative phosphoproteomics as a powerful strategy for dissecting natural product mediated regulation of oncogenic signaling and provides mechanistic insight into the anticancer potential of Annona muricata .